Who
Yujiro S. Hata
President and CEO
Company insider
Files Form 4 as: President and CEO, IDEAYA Biosciences; Director, Enanta Pharmaceuticals; Director, Xencor.
In numbers
- Trades disclosed
- 70
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $18.5M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 30 Jul 2015
- Last trade
- 6 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Oct 2026filed 8 Oct 2026 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Code M | $114K26,338 at $4.31 | filing |
| 6 Oct 2026filed 8 Oct 2026 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Sold | $955K25,538 at $37.39 | filing |
| 6 Oct 2026filed 8 Oct 2026 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Sold | $31K800 at $38.26 | filing |
| 6 Oct 2026filed 8 Oct 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —26,338 at $0.00 | filing |
| 11 Mar 2026filed 13 Mar 2026 | ENTA Enanta Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 11 Mar 2026filed 13 Mar 2026 | ENTA Enanta Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 30 Jan 2026filed 2 Feb 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 30 Jan 2026filed 2 Feb 2026 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 13 Mar 2025filed 14 Mar 2025 | ENTA Enanta Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,700 at $0.00 | filing |
| 27 Feb 2025filed 28 Feb 2025 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —600,000 at $0.00 | filing |
| 18 Feb 2025filed 19 Feb 2025 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,808 at $0.00 | filing |
| 18 Feb 2025filed 19 Feb 2025 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Code M | $250K12,808 at $19.52 | filing |
| 16 May 2024filed 16 May 2024 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —34,433 at $0.00 | filing |
| 16 May 2024filed 16 May 2024 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Code M | $148K34,433 at $4.31 | filing |
| 16 May 2024filed 16 May 2024 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Sold | $1.3M30,084 at $41.73 | filing |
| 16 May 2024filed 16 May 2024 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Sold | $184K4,349 at $42.37 | filing |
| 15 May 2024filed 16 May 2024 | IDYA IDEAYA Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —83,856 at $0.00 | filing |
| 15 May 2024filed 16 May 2024 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Code M | $361K83,856 at $4.31 | filing |
| 15 May 2024filed 16 May 2024 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Sold | $2.3M53,592 at $42.57 | filing |
| 15 May 2024filed 16 May 2024 | IDYA IDEAYA BiosciencesBiotechnology | SEC FORM 4 Sold | $1.3M29,761 at $43.48 | filing |
News
No headline names them, or the companies they trade most, lately.